Body surface area is an independent factor contributing to the effects of lamivudine treatment

Hepatology Research

Volumn 31, Issue 1, 2005, Pages 13-17

  Nakamuta, Makoto ^a   Kotoh, Kazuhiro ^a   Tanabe, Yuichi ^b   Kajiwara, Eiji ^c   Shimono, Junya ^d   Masumoto, Akihide ^e   Maruyama, Toshihiro ^f   Furusyo, Norihiro ^a   Nomura, Hideyuki ^g   Sakai, Hironori ^e   Takahashi, Kazuhiro ^h   Azuma, Koichi ^a   Shimoda, Shinji ^a   Enjoji, Munechika ^a   Hayashi, Jun ^a   Sugimoto, R ⁱ   Amagase, H ^j   Tominaga, S ^j   Yanagita, K ^k   Ogiwara, K ^l   Tokumatsu, M ^m   Tabata, S ⁿ   Yokota, M ^o   Tanaka, H ^p   Nagase, S ^q   Tsuruta, S ^r   Tada, S ^s   Nagano, M ^t   Honda, M ^u   Umeno, T ^v   Sugimura, T ^e   Ueno, S ^w   Miki, K ^x   Okubo, H ^y   Fujimoto, H ^z   Higuchi, N ^aa   Shigematsu, S ^ab   Higashi, N ^ac   more..

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka City Hospital   (Japan)

^c STEEL MEMORIAL YAWATA HOSPITAL   (Japan)

^d Saiseikai Yahata Hospital   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

^f KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^g Shin Kokura Hospital   (Japan)

^h HAMANOMACHI HOSPITAL   (Japan)

ⁱ HARASANSHIN HOSPITAL   (Japan)

^j Mihagino Hospital   (Japan)

^k Saiseikai Karatsu Hospital   (Japan)

^l KYUSHU ROSAI HOSPITAL   (Japan)

^m Saiseikai Fukuoka Hospital   (Japan)

ⁿ Hayashi Eye Hospital   (Japan)

^o NATIONAL KYUSHU CANCER CENTER   (Japan)

^p CHIHAYA HOSPITAL   (Japan)

^q Fukuoka Teishin Hospital   (Japan)

^r Nakabaru Hospital   (Japan)

^s Moji Rosai Hospital   (Japan)

^t KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^u Nishi Fukuoka Hospital   (Japan)

^v Sawara Hospital   (Japan)

^w University of Occupational and Environmental Health School of Medicine   (Japan)

^x Japanese Seamen's Relief Association   (Japan)

^y Shineikai Hospital   (Japan)

^z Mitusbishikagaku Hospital   (Japan)

^aa Shin Nakama Hospital   (Japan)

^ab Saga Prefectural Hospital Kouseikan   (Japan)

^ac NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

more..

Author keywords

Body surface area (BSA); Dose; Hepatitis B virus (HBV); Lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; BOVINE SERUM ALBUMIN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY SURFACE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE COUNT;

EID: 19944427252     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.11.004     Document Type: Article

References (13)

1. D. Ganem A.M. Prince Hepatitis B virus infection-natural history and clinical consequences N Engl J Med 350 2004 1118-1129
2. C.L. Lai V. Ratziu M.-F. Yuen T. Poynard Viral hepatitis B Lancet 362 2003 2089-2094
3. J.L. Dienstag R.P. Perrillo E.R. Schiff M. Bartholomew C. Vicary M. Rubin A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1995 1657-1661
4. F. Nevens J. Main P. Honkoop et al. Lamivudine therapy for chronic hepatitis B: A six-month randomized dose-ranging study Gastroenterology 113 1997 1258-1263
5. M. Kohmoto M. Enomoto Y. Yano et al. Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: Comparison with three other assays Hepatol Res 26 2003 125-133
6. H. Sakugawa K. Kobashigawa T. Nakayoshi et al. Monitoring low level hepatitis B virus by a newly developed sensitive test Hepatol Res 26 2003 281-286
7. P. Honkoop R.A. de Man H.G. Niesters et al. Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: Evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy J Viral Hepat 5 1998 307-312
8. S. Ohkoshi N. Ogata T. Ichida The long-term clinical outcome of 1-year treatment of chronic hepatitis B with lamivudine-5 years observation Hepatol Res 27 2003 13-17
9. Y.F. Liaw N.W.Y. Leung T.T. Chang et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 119 2000 172-180
10. L.M.M. Wolters H.G.M. Niesters B.E. Hunsen et al. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort J Clin Virol 24 2002 173-181
11. M.A. Johnson K.H. Moore G.J. Yuen A. Bye G.E. Pakes Clinical pharmacokinetics of lamivudine Clin Pharmacokinet 36 1999 41-66
12. T. Ide R. Kumashiro Y. Koga et al. A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine Am J Gastroenterol 98 2003 2048-2051
13. H.L. Zaaijer F. ter Borg H.T. Cuypers M.C. Hermus P.N. Lelie Comparison of methods for detection of hepatitis B virus DNA J Clin Microbiol 323 1994 2088-2091